MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3171/2024.5.jns24623

Медицинская библиотека · Journal of neurosurgery · 2024

Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial.

Darsaut Tim E, Gentric Jean-Christophe, Heppner Jonathan, Lopez Camille, Jabre Roland, Iancu Daniela, Roy Daniel, Weill Alain, Bojanowski Michel W, Chaalala Chiraz, Comby Pierre-Olivier, Roberge David, Cognard Christophe, Januel Anne-Christine, Sabatier Jean-Francois, Desal Hubert, Roualdes Vincent, Ferre Jean-Christophe, Alias Quentin, Papagiannaki Chrysanthi, Derrey Stéphane, Smajda Stanislas, Aldea Sorin, Gaberel Thomas, Barbier Charlotte, Barreau Xavier, Marnat Gaultier, Jecko Vincent, Anxionnat Rene, Merlot Isabelle, Nguyen Thanh N, Abdalkader Mohamad, Dumot Chloe, Riva Roberto, Graillon Thomas, Troude Lucas, Kerleroux Basile, Ollivier Irene, Beaujeux Remy, Boulouis Grégoire, Planty-Bonjour Alexia, Spelle Laurent, Chalumeau Vanessa, Naggara Olivier, Lefevre Pierre-Henri, Le Corre Marine, Shotar Eimad, Carlson Andrew P, Biondi Alessandra, Thines Laurent, Tawk Rabih G, Huynh Thien, Fahed Robert, Findlay J Max, Chabert Emmanuel, Zehr Justine, Gevry Guylaine, Klink Ruby, Viard Geraldine, Magro Elsa, Raymond Jean, the TOBAS Collaborative Group

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

Many patients recruited in the Treatment of Brain Arteriovenous Malformations Study (TOBAS) are managed conservatively. The aim of this study was to monitor what happened to those patients.

METHODS

TOBAS comprises two randomized controlled trials and multiple prospective registries. All patients with brain arteriovenous malformations (AVMs) can participate. This report concerns patients selected for conservative management. The primary trial outcome measure is related death or dependency (modified Rankin Scale [mRS] score > 2) at 10 years. Secondary outcomes include intracranial hemorrhages, nonhemorrhagic neurological events, and serious adverse events (SAEs). For this report, outcome results are presented using patient-years, Kaplan-Meier survival curves, and Cox log-rank tests. There was no blinding.

RESULTS

From June 2014 to May 2021, 1010 patients were recruited, of whom 498 (49%) were proposed the prospective observation registry. After exclusions, 434 (87%) patients remained for analysis. The majority of patients had unruptured AVMs (378/434 [87%]), of which 195 (52%) were low grade (Spetzler-Martin grade I or II). During a mean follow-up period of 3.2 years (total 1368 patient-years), the primary outcome occurred in 23 of 434 (5%) patients, corresponding to an incidence of 1.7 (95% CI 1.1-2.5) per 100 patient-years. For unruptured AVMs the incidence was 1.1 (95% CI 0.7-1.9) per 100 patient-years, and for low-grade unruptured AVMs it was 0.6 (95% CI 0.2-1.7) per 100 patient-years. Poor outcomes were more frequent in patients with a history of rupture (HR 5.6 [95% CI 2.4-13.0], p < 0.001), infratentorial AVMs (HR 2.9 [95% CI 1.1-7.3], p = 0.027), and age ≥ 55 years (HR 3.2 [95% CI 1.4-7.6], p = 0.007). Major intracranial hemorrhage occurred in 35 of 434 (8%) patients (incidence of 2.6 [95% CI 1.9-3.6] per 100 patient-years; 2.0 [95% CI 1.3-2.9] per 100 patient-years for unruptured AVMs and 1.3 [95% CI 0.6-2.6] per 100 patient-years for low-grade unruptured AVMs). Major AVM hemorrhages were more frequent in ruptured (HR 4.4 [95% CI 2.1-8.9], p < 0.001), large (HR 2.6 [95% CI 1.1-6.6], p = 0.039), and high-grade (HR 2.5 [95% CI 1.2-5.3], p = 0.013) AVMs and those with deep venous drainage (HR 2.1 [95% CI 1.1-4.2], p = 0.032). SAEs occurred in 48 of 434 (11%) patients (incidence of 3.6 [95% CI 2.7-4.8] per 100 patient-years). For unruptured AVMs the incidence was 2.8 (95% CI 2.0-4.0) per 100 patient-years, and for low-grade unruptured AVMs it was 1.8 (95% CI 1.0-3.2) per 100 patient-years.

CONCLUSIONS

Nearly half of TOBAS participants were observed. Rates of untoward neurological events were within expected boundaries.

Для цитирования: Darsaut Tim E, Gentric Jean-Christophe, Heppner Jonathan, Lopez Camille, Jabre Roland, Iancu Daniela, Roy Daniel, Weill Alain, Bojanowski Michel W, Chaalala Chiraz, Comby Pierre-Olivier, Roberge David, Cognard Christophe, Januel Anne-Christine, Sabatier Jean-Francois, Desal Hubert, Roualdes Vincent, Ferre Jean-Christophe, Alias Quentin, Papagiannaki Chrysanthi, Derrey Stéphane, Smajda Stanislas, Aldea Sorin, Gaberel Thomas, Barbier Charlotte, Barreau Xavier, Marnat Gaultier, Jecko Vincent, Anxionnat Rene, Merlot Isabelle, Nguyen Thanh N, Abdalkader Mohamad, Dumot Chloe, Riva Roberto, Graillon Thomas, Troude Lucas, Kerleroux Basile, Ollivier Irene, Beaujeux Remy, Boulouis Grégoire, Planty-Bonjour Alexia, Spelle Laurent, Chalumeau Vanessa, Naggara Olivier, Lefevre Pierre-Henri, Le Corre Marine, Shotar Eimad, Carlson Andrew P, Biondi Alessandra, Thines Laurent, Tawk Rabih G, Huynh Thien, Fahed Robert, Findlay J Max, Chabert Emmanuel, Zehr Justine, Gevry Guylaine, Klink Ruby, Viard Geraldine, Magro Elsa, Raymond Jean, the TOBAS Collaborative Group. Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial.. Journal of neurosurgery. 2024. DOI: 10.3171/2024.5.jns24623.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.